Research and Clinical Trials

The Carle Cancer Center has participated in cancer research for over 20 years, and in 1983, was one of the first community cancer facilities in the United States to be designated as a Community Clinical Oncology Program (CCOP). Through this designation, the Carle Cancer Center is linked directly with the National Cancer Institute’s research endeavors.

The Carle Cancer Center’s primary research affiliation is with the North Central Cancer Treatment Group (NCCTG), which is directly affiliated with and headed by the Mayo Clinic in Rochester, Minnesota. In addition to NCCTG, the Carle Cancer Center participates in other research programs including the Eastern Cooperative Oncology Group (ECOG), the oldest and largest clinical trials group in the country, and the National Surgical Adjuvant Breast and Bowel Project (NSABP), which has developed innovative treatments in breast cancer therapy.

Currently, the Carle Cancer Center is participating in over 125 research projects including national studies aimed at developing therapies to aid in cancer prevention, especially in breast, prostate, lung and colon cancers.

The following is a list of sites for which we offer clinical trials. For more information about specific trials offered, please call the Carle Cancer Center’s Research and Prevention office at (800) 446-5532.